Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - nebivolol hydrochloride 5,45 mg - eq. nebivolol 5 mg - tablet - 5 mg - nebivolol hydrochloride 5.45 mg - nebivolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - nebivolol hydrochloride 5,45 mg - eq. nebivolol 5 mg - tablet - 5 mg - nebivolol hydrochloride 5.45 mg - nebivolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - nebivolol hydrochloride 5,45 mg - eq. nebivolol 5 mg - tablet - 5 mg - nebivolol hydrochloride 5.45 mg - nebivolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - nebivolol hydrochloride 5,45 mg - eq. nebivolol 5 mg - tablet - 5 mg - nebivolol hydrochloride 5.45 mg - nebivolol

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - nebivolol hydrochloride 5,45 mg - eq. nebivolol 5 mg - tablet - 5 mg - nebivolol hydrochloride 5.45 mg - nebivolol

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - nebivolol hydrochloride - oral tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - nebivolol hydrochloride - oral tablet - 10mg

United States - English - NLM (National Library of Medicine)

modavar pharmaceuticals llc - nebivolol hydrochloride (unii: jgs34j7l9i) (nebivolol - unii:030y90569u) - nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see clinical studies ( 14.1 ) ]. nebivolol may be used alone or in combination with other antihypertensive agents [see drug interactions ( 7 )]. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nebivolol. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as

United States - English - NLM (National Library of Medicine)

cadila pharmaceuticals limited - nebivolol hydrochloride (unii: jgs34j7l9i) (nebivolol - unii:030y90569u) - nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see clinical studies ( 14.1 ) ]. nebivolol may be used alone or in combination with other antihypertensive agents [see drug interactions ( 7 )]. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nebivolol. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as

United States - English - NLM (National Library of Medicine)

lifestar pharma llc - nebivolol hydrochloride (unii: jgs34j7l9i) (nebivolol - unii:030y90569u) - nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see clinical studies (14.1)]. nebivolol tablets may be used alone or in combination with other antihypertensive agents [see drug interactions (7)]. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nebivolol tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelin